Block of human aorta Kir6.1 by the vascular KATP channel inhibitor U37883A

A human aorta cDNA library was screened at low stringency with a rat pancreatic Kir6.1 cDNA probe and a homologue of Kir6.1 (hKir6.1) was isolated and sequenced. Metabolic poisoning of Xenopus laevis oocytes with sodium azide and application of the K+ channel opener drug diazoxide induced K+ channel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:British journal of pharmacology 1999-10, Vol.128 (3), p.667-672
Hauptverfasser: Surah‐Narwal, S, Xu, S Z, McHugh, D, McDonald, R L, Hough, E, Cheong, A, Partridge, C, Sivaprasadarao, A, Beech, D J
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:A human aorta cDNA library was screened at low stringency with a rat pancreatic Kir6.1 cDNA probe and a homologue of Kir6.1 (hKir6.1) was isolated and sequenced. Metabolic poisoning of Xenopus laevis oocytes with sodium azide and application of the K+ channel opener drug diazoxide induced K+ channel currents in oocytes co‐injected with cRNA for hKir6.1 and hamster sulphonylurea receptor (SUR1), but not in oocytes injected with water or cRNA for hKir6.1 or SUR1 alone. K+ channel currents due to hKir6.1+SUR1 or mouse Kir6.2+SUR1 were strongly inhibited by 1 μM glibenclamide. K+‐current carried by hKir6.1+SUR1 was inhibited by the putative vascular‐selective KATP channel inhibitor U37883A (IC50 32 μM) whereas current carried by Kir6.2+SUR1 or Shaker K+ channels was unaffected. The data support the hypothesis that hKir6.1 is a component of the vascular KATP channel, although the lower sensitivity of hKir6.1+SUR1 to U37883A compared with native vascular tissues suggests the need for another factor or subunit. Furthermore, the data suggest that pharmacology of KATP channels can be determined by the pore‐forming subunit as well as the sulphonylurea receptor and point to a molecular basis for the pharmacological distinction between vascular and pancreatic/cardiac KATP channels. British Journal of Pharmacology (1999) 128, 667–672; doi:10.1038/sj.bjp.0702862
ISSN:0007-1188
1476-5381
DOI:10.1038/sj.bjp.0702862